KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Staar Surgical (STAA) Shares Outstanding (Diluted Average) (2021 - 2026)

Staar Surgical's Shares Outstanding (Diluted Average) history spans 12 years, with the latest figure at $49.6 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 0.9% year-over-year to $49.6 million; the TTM value through Jan 2026 reached $49.6 million, up 0.9%, while the annual FY2026 figure was $49.6 million, 0.9% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $49.6 million in Q1 2026 per STAA's latest filing, down from $50.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $50.5 million in Q3 2025 to a low of $48.9 million in Q1 2024.
  • Average Shares Outstanding (Diluted Average) over 5 years is $49.5 million, with a median of $49.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): fell 1.2% in 2024, then rose 1.88% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $49.4 million in 2022, then grew by 0.1% to $49.4 million in 2023, then dropped by 0.61% to $49.1 million in 2024, then rose by 2.9% to $50.5 million in 2025, then fell by 1.94% to $49.6 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Shares Outstanding (Diluted Average) are $49.6 million (Q1 2026), $50.5 million (Q3 2025), and $49.4 million (Q2 2025).